IL-17 was found to promote osteoclastogenesis, in a mice model of ovariectomy- (OVX-) induced osteoporosis, by stimulating RANKL expression by osteoblasts via the IL-17RA SEFIR/TILL. Here, IL17A is linked to osteoporosis.